Synthesis and In Vitro skin permeation of naproxen conjugates with α-alkylamino acids

Current Drug Delivery

Volumn 2, Issue 2, 2005, Pages 185-189

  Pignatello, Rosario ^a   Montenegro, Lucia ^a   Stancampiano, Annalisa H S ^a   Puleo, Antonina ^a   Puglisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

2 alkylamino acids; Dermal delivery; Lipophilicity; Naproxen; Prodrugs

Indexed keywords

ALPHA AMINO ACID; NAPROXEN;

ANALGESIA; ANALYTIC METHOD; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONJUGATE; COUPLING FACTOR; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; LIPOPHILICITY; PRIORITY JOURNAL; SKIN PERMEABILITY; THROMBOCYTE AGGREGATION INHIBITION;

ADULT; ANIMALS; DRUG STABILITY; HUMANS; MALE; MICE; NAPROXEN; PERMEABILITY; PRODRUGS; SKIN; SOLUBILITY;

EID: 16844380824     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567201053585976     Document Type: Article

References (27)

1. Lambert, D.M. Eur. J. Pharm. Sci., 2000, 11 (Suppl, 2), 15-27.
2. Sloan, K.B. Adv. Drug Del. Rev., 1989, 3, 67-101.
3. Lambert, D.M.; Scriba, G.K.E.; Gallez, B.; Poupaert, J.H.; Dumont, P. Curr. Med. Chem., 1995, 1, 376-91.
4. Yano, T.; Nakagawa, A.; Tsuji, M. Life Sci., 1986, 39, 1043-50.
5. Bonina, F.P.; Montenegro, L.; Guerrera, F. Int. J. Pharm., 1993. 100, 99-105.
6. Weber, H.; Meyer-Trümpener, K.; Lippold, B.C. Arch. Pharm. (Weinheim), 1994, 327, 681-6.
7. Rautio, J.; Nevelainen, T.; Taipale, H.; Vepsalainen, J.; Gynther, J.; Pedersen, T.; Jarvinen T. Pharm. Res., 1999, 16, 1172-8.
8. Rautio, J.; Nevelainen, T.; Taipale, H.; Vepsalainen, J.; Gynther, J.; Laine, K.; Jarvinen, T. Eur. J. Pharm Sci., 2000, 11, 157-63.
9. Bonina, F.P.; Puglia, C.; Barbuzzi, T.; De Caprariis, P.; Palagiano, F.; Rimoli, M.G.; Saija, A. Eur. J. Pharm. Sci., 2001, 14, 123-34.
10. Mendes, E.; Furtado, T.; Neres, J.; Iley, J.; Jarvinen, T.; Rautio, J.; Moreira, R. Bioorg. Med. Chem., 2002, 10, 809-16.
11. Toth, I. J. Drug Targeting. 1994, 2, 217-39.
12. Wong, A.; Toth, I. Curr. Med. Chem., 2001, 8, 1123-36.
13. Pignatello, R.; Jansen, G.; Kathniann, I.; Puglisi, G.; Toth, I. J. Pharm. Sci., 1998, 87, 367-71.
14. Pignatello, R.; Spampinato, G.; Sorrenti, V.; Di Giacomo, C.; Vicari, L.; McGuire, J.J.; Rüssel, C.A.; Puglisi, G.; Toth, I. Eur. J. Pharm. Sci., 2000, 10, 237-45.
15. Pignatello, R.; Puleo, A.; Giustolisi, S.; Cuzzocrea, S.; Dugo, L.; Caputi, A.P.; Puglisi, G. Drug Dev. Res., 2002, 57, 115-21.
16. Pignatello, R.; Puleo, A.; Acquaviva, R.; Di Giacomo, C., Vanella, A.; Puglisi, G. J. Drug Del. Sci. Tech., 2004, 14, 181-6.
17. Bradford, M.M. Anal. Biochem., 1976, 72, 248-54.
18. Kligman, A.M.; Christophers, E. Arch. Dermatol., 1963, 88, 702-5.
19. Zerrouk, N.; Mennini, N.; Maestrelli, F.; Chemtob, C.; Mura, P. Eur. J. Pharm. Biopharm., 2004, 57, 93-9.
20. Bronaugh, R.L.; Stewart, R.F. J. Pharm. Sci., 1984, 73, 1255-58.
21. Bundgaard, H.; Mork, N.; Hoelgaard, A., Int. J. Pharm., 1989, 55, 91-977
22. Sloan, K.B. Adv. Drug Del. Rev., 1989, 3, 67-101.
23. Waranis, R.P.; Sloan, K.B. J. Pharm. Sci., 1987, 76, 587-95.
24. Roberts, W.J.; Sloan, K.B. J. Pharm. Sci., 1999, 88, 515-32.
25. Roberts, W.J.; Sloan, K.B. J. Pharm. Sci., 2000, 89, 1415-31.
26. Sloan, K.B.; Scott, W.; Ezike-Mkparu, U.; Murray, T.; Nickels, D.; Singh, S.; Shanks, T.; Tovar, J.; Ulmer, K.; Waranis, R. Pharm. Res., 2003, 4, 639-45.
27. Plemper van Balen, G.; Marca Martinet, C.A.; Caron, G.; Bouchard, G.; Reist, M.; Carrupt, P-A.; Frutlcro, R.; Gasco, A.; Testa, B. Med. Res. Rev., 2004, 24, 299-324.